Tag: HEA MTC OTC PHA BIO

Emmaus Life Sciences Reports Quarterly Financial Results

TORRANCE, Calif., Aug. 14, 2025 /PRNewswire/ -- Emmaus Life Sciences, Inc. (OTCQB: EMMA), a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell...

- A word from our sponsors -

Newsletter Signup

Name(Required)

First Last

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

This field is for validation purposes and should be left unchanged.

HomeTagsHEA MTC OTC PHA BIO

EU Good Food Fruits Add a Fresh Accent to Korea’s Culinary Scene

24/7 Market News: LIXTE Biotech Advances Precision Oncology Pipeline with First Phase 1B/2 Trial Readout Expected in 2H 2025

Believe in Blytheville Schools: AMS Impact Group Launches Bold Educational Revitalization Effort

Tag: HEA MTC OTC PHA BIO

Emmaus Life Sciences Reports Quarterly Financial Results

Newsletter Signup

Explore

Press Releases

News & Opinion

Living

Others

Follow us